Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07013435 · ClinicalTrials.gov registry record · NA
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT07013435: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT07013435 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 254 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07013435, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
Interventions
- OTHER Health Education Program
- OTHER SMART3RP-Lymphoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2026-07-20 |
| Est. Completion | 2030-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07013435
The ClinicalTrials.gov registry entry for NCT07013435 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Education Program is the first listed.
NCT07013435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07013435 about?
NCT07013435 is a clinical study titled "A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship". The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.
What is the current status of trial NCT07013435?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 254 participants. The study started on 2026-07-20. Estimated completion is 2030-08.
What interventions are being tested in trial NCT07013435?
The interventions under investigation include: Health Education Program (OTHER), SMART3RP-Lymphoma (OTHER).
Who is sponsoring clinical trial NCT07013435?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.